 | • レポートコード：MRC2304D095 • 出版社/出版日：Transparency Market Research / 2023年1月16日 • レポート形態：英文、PDF、252ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の当調査レポートでは、血行動態モニタリングシステムの世界市場を分析し、市場実態を明らかにしています。本書は、序論、仮定＆調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品別（モニター、消耗品）分析、技術種類別（侵襲的、非侵襲的）分析、エンドユーザー別（病院、カテーテル検査室、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを収録しています。また、Koninklijke Philips N.V.、ICU Medical、Medtronic、GE HealthCare、Edwards Lifesciences Corporation、Baxter、Biocare Medical, LLC.、Uscom、NOGA MEDICAL、Comen、Creative Industry、Dräger、EMTEL Śliwa sp.k.、General Meditech、Mars Medical Products、UTAS Co.、Vytech、Masimoなどの企業情報を掲載しています。 ・序論 ・仮定＆調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界の血行動態モニタリングシステム市場規模：製品別 - モニターの市場規模 - 消耗品の市場規模 ・世界の血行動態モニタリングシステム市場規模：技術種類別 - 侵襲的モニタリングシステムの市場規模 - 非侵襲的モニタリングシステムの市場規模 ・世界の血行動態モニタリングシステム市場規模：エンドユーザー別 - 病院における市場規模 - カテーテル検査室における市場規模 - その他エンドユーザーにおける市場規模 ・世界の血行動態モニタリングシステム市場規模：地域別 - 北米の血行動態モニタリングシステム市場規模 - ヨーロッパの血行動態モニタリングシステム市場規模 - アジア太平洋の血行動態モニタリングシステム市場規模 - 中南米のアルミニウムスラグ市場規模 - 中東・アフリカのアルミニウムスラグ市場規模 ・競争状況 |
Hemodynamic Monitoring Systems Market – Scope of Report
TMR’s report on the global hemodynamic monitoring systems market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global hemodynamic monitoring systems market for the period 2017–2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global hemodynamic monitoring systems market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the hemodynamic monitoring systems market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global hemodynamic monitoring systems market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global hemodynamic monitoring systems market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global hemodynamic monitoring systems market.
The report delves into the competitive landscape of the global hemodynamic monitoring systems market. Key players operating in the global hemodynamic monitoring systems market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global hemodynamic monitoring systems market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market hemodynamic monitoring systems.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
• Industry Sources:
o WorldWideScience.org
o Elsevier, Inc.
o National Institutes of Health (NIH)
o PubMed
o NCBI
o Department of Health Care Service
• Trade Data Sources
o Trade Map
o UN Comtrade
o Trade Atlas
• Company Information
o OneSource Business Browser
o Hoover’s
o Factiva
o Bloomberg
• Mergers & Acquisitions
o Thomson Mergers & Acquisitions
o MergerStat
o Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Hemodynamic Monitoring Systems Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Hemodynamic Monitoring Systems Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Mergers & Acquisitions
5.2. Disease Prevalence & Incidence Rate globally with key countries
5.3. Technological Advancements
5.4. Key product/brand Analysis
5.5. Pricing Analysis
5.6. COVID-19 Pandemic Impact on Industry
6. Global Hemodynamic Monitoring Systems Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Monitors
6.3.2. Consumables
6.3.2.1. Pressure Tubing
6.3.2.2. Flush Device
6.3.2.3. Transducers
6.3.2.4. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Hemodynamic Monitoring Systems Market Analysis and Forecast, by Technique Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Technique Type, 2017–2031
7.3.1. Invasive
7.3.2. Non-invasive
7.4. Market Attractiveness Analysis, by Technique Type
8. Global Hemodynamic Monitoring Systems Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Cath Labs
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Hemodynamic Monitoring Systems Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Hemodynamic Monitoring Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Monitors
10.2.2. Consumables
10.2.2.1. Pressure Tubing
10.2.2.2. Flush Device
10.2.2.3. Transducers
10.2.2.4. Others
10.3. Market Value Forecast, by Technique Type, 2017–2031
10.3.1. Invasive
10.3.2. Non-invasive
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Cath Labs
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Technique Type
10.6.3. By End-user
10.6.4. By Country
11. Europe Hemodynamic Monitoring Systems Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Monitors
11.2.2. Consumables
11.2.2.1. Pressure Tubing
11.2.2.2. Flush Device
11.2.2.3. Transducers
11.2.2.4. Others
11.3. Market Value Forecast, by Technique Type, 2017–2031
11.3.1. Invasive
11.3.2. Non-invasive
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Cath Labs
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Technique Type
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Hemodynamic Monitoring Systems Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Monitors
12.2.2. Consumables
12.2.2.1. Pressure Tubing
12.2.2.2. Flush Device
12.2.2.3. Transducers
12.2.2.4. Others
12.3. Market Value Forecast, by Technique Type, 2017–2031
12.3.1. Invasive
12.3.2. Non-invasive
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Cath Labs
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Technique Type
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Hemodynamic Monitoring Systems Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Monitors
13.2.2. Consumables
13.2.2.1. Pressure Tubing
13.2.2.2. Flush Device
13.2.2.3. Transducers
13.2.2.4. Others
13.3. Market Value Forecast, by Technique Type, 2017–2031
13.3.1. Invasive
13.3.2. Non-invasive
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Cath Labs
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Technique Type
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Hemodynamic Monitoring Systems Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Monitors
14.2.2. Consumables
14.2.2.1. Pressure Tubing
14.2.2.2. Flush Device
14.2.2.3. Transducers
14.2.2.4. Others
14.3. Market Value Forecast, by Technique Type, 2017–2031
14.3.1. Invasive
14.3.2. Non-invasive
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Cath Labs
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Technique Type
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. Koninklijke Philips N.V.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Type Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. ICU Medical
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Type Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Medtronic
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Type Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. GE HealthCare
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Type Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Edwards Lifesciences Corporation
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Type Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Baxter
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Type Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Biocare Medical, LLC.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Type Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Uscom
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Type Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. NOGA MEDICAL
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Type Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Comen
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Type Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
15.3.11. Creative Industry
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Product Type Portfolio
15.3.11.3. Financial Overview
15.3.11.4. SWOT Analysis
15.3.11.5. Strategic Overview
15.3.12. Dräger
15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.12.2. Product Type Portfolio
15.3.12.3. Financial Overview
15.3.12.4. SWOT Analysis
15.3.12.5. Strategic Overview
15.3.13. EMTEL Śliwa sp.k.
15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.13.2. Product Type Portfolio
15.3.13.3. Financial Overview
15.3.13.4. SWOT Analysis
15.3.13.5. Strategic Overview
15.3.14. General Meditech
15.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.14.2. Product Type Portfolio
15.3.14.3. Financial Overview
15.3.14.4. SWOT Analysis
15.3.14.5. Strategic Overview
15.3.15. Mars Medical Products
15.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.15.2. Product Type Portfolio
15.3.15.3. Financial Overview
15.3.15.4. SWOT Analysis
15.3.15.5. Strategic Overview
15.3.16. UTAS Co.
15.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.16.2. Product Type Portfolio
15.3.16.3. Financial Overview
15.3.16.4. SWOT Analysis
15.3.16.5. Strategic Overview
15.3.17. Vytech
15.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.17.2. Product Type Portfolio
15.3.17.3. Financial Overview
15.3.17.4. SWOT Analysis
15.3.18. Masimo
15.3.18.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.18.2. Product Type Portfolio
15.3.18.3. Financial Overview
15.3.18.4. SWOT Analysis
15.3.18.5. Strategic Overview